MAIA Pharmaceuticals Overview
- Year Founded
-
2013
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
MAIA Pharmaceuticals General Information
Description
Operator of a special pharmaceutical company intended to market injectable products for unmet medical needs. The company's leading drug candidate Sincalide is an injectable drug used to stimulate gallbladder contraction, enabling heath care practitioners to accelerate the transit of a barium meal through the small bowel, thereby decreasing the time and extent of radiation associated with fluoroscopy and x-ray examination of the intestinal tract
Contact Information
Website
www.maiapharma.comCorporate Office
- 707 State Road
- Suite 104
- Princeton, NJ 08540
- United States
Corporate Office
- 707 State Road
- Suite 104
- Princeton, NJ 08540
- United States
MAIA Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Out of Business | 01-Apr-2020 | Completed | Out of Business | |||
| 2. Early Stage VC (Series A) | 12-Nov-2014 | Completed | Startup | |||
| 1. Corporate | 23-Apr-2013 | $1.4M | $1.4M | Completed | Startup |
MAIA Pharmaceuticals Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | ||||||||
| Seed |
MAIA Pharmaceuticals Patents
MAIA Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260137753-A1 | Daptomycin compositions | Pending | 21-Nov-2024 | ||
| WO-2026111848-A1 | Daptomycin compositions | Pending | 21-Nov-2024 | ||
| EP-4701631-A1 | Levothyroxine dispersions | Pending | 28-Apr-2023 | ||
| US-20260294858-A1 | Levothyroxine dispersions | Pending | 28-Apr-2023 | ||
| WO-2024224373-A1 | Levothyroxine dispersions | Inactive | 28-Apr-2023 | A61K9/0019 |
MAIA Pharmaceuticals FAQs
-
When was MAIA Pharmaceuticals founded?
MAIA Pharmaceuticals was founded in 2013.
-
Where is MAIA Pharmaceuticals headquartered?
MAIA Pharmaceuticals is headquartered in Princeton, NJ.
-
What industry is MAIA Pharmaceuticals in?
MAIA Pharmaceuticals’s primary industry is Pharmaceuticals.
-
Is MAIA Pharmaceuticals a private or public company?
MAIA Pharmaceuticals is a Private company.
-
What is MAIA Pharmaceuticals’s current revenue?
The current revenue for MAIA Pharmaceuticals is .
-
How much funding has MAIA Pharmaceuticals raised over time?
MAIA Pharmaceuticals has raised $2.25M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process